West Michigan Advisors’s AstraZeneca AZN Stock Holding History

West Michigan Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$310K	Sell	1,636 -2	-0.1%	-$376	0.06%	232
2026 Q1	$323K	Sell	1,638 -405	-20%	-$78.1K	0.07%	220
2025 Q4	$376K	Sell	2,043 -132	-6%	-$23.2K	0.09%	186
2025 Q3	$334K	Buy	2,175 +434	+25%	+$65.7K	0.08%	195
2025 Q2	$243K	Buy	+1,741	New	+$244K	0.07%	203
2024 Q4	–	Sell	-1,300	Closed	-$203K	–	229
2024 Q3	$203K	Sell	1,300 -1,635	-56%	-$264K	0.06%	184
2024 Q2	$458K	Sell	2,935 -41	-1%	-$6.17K	0.15%	107
2024 Q1	$403K	Buy	2,976 +361	+14%	+$47.8K	0.13%	108
2023 Q4	$352K	Sell	2,615 -1,280	-33%	-$166K	0.13%	97
2023 Q3	$528K	Buy	3,895 +615	+19%	+$84K	0.28%	74
2023 Q2	$469K	Sell	3,280 -347	-10%	-$51.1K	0.19%	116
2023 Q1	$503K	Buy	+3,627	New	+$488K	0.29%	77

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

West Michigan Advisors's AZN Position: Q2 2026 in Review

West Michigan Advisors reduced its AstraZeneca (AZN) stake by 0.12% in Q2 2026, selling an estimated $376 and leaving 1,636 shares worth $310K. The position accounts for 0.06% of the portfolio, ranked #232.

West Michigan Advisors first reported a position in AZN in Q1 2023 and has held it in 12 quarters since. The position peaked at $528K in Q3 2023. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

West Michigan Advisors held 1,636 shares of AstraZeneca worth $310K as of Q2 2026.
West Michigan Advisors sold 2 AstraZeneca shares in Q2 2026, an estimated $376.
AstraZeneca made up 0.06% of West Michigan Advisors's portfolio in Q2 2026, its #232 holding.
West Michigan Advisors first reported a position in AstraZeneca in Q1 2023 and has held it in 12 quarters since.
West Michigan Advisors's AstraZeneca position peaked at $528K in Q3 2023.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.